Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Pankaj Singh and Surendra Shukla.
Pankaj Singh
Connection Strength
8.409
Surendra Shukla
  1. Molecular and Physiological Evaluation of Pancreatic Cancer-Induced Cachexia. Methods Mol Biol. 2019; 1882:321-333.
    View in: PubMed
    Score: 0.656
  2. Transcriptional Profiling Using RNA-Seq to Study Hypoxia-Mediated Gene Regulation. Methods Mol Biol. 2018; 1742:55-66.
    View in: PubMed
    Score: 0.612
  3. Hypoxia-Mediated In Vivo Tumor Glucose Uptake Measurement and Analysis. Methods Mol Biol. 2018; 1742:107-113.
    View in: PubMed
    Score: 0.612
  4. MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer. Cancer Cell. 2017 09 11; 32(3):392.
    View in: PubMed
    Score: 0.599
  5. MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer. Cancer Cell. 2017 07 10; 32(1):71-87.e7.
    View in: PubMed
    Score: 0.592
  6. Silibinin-mediated metabolic reprogramming attenuates pancreatic cancer-induced cachexia and tumor growth. Oncotarget. 2015 Dec 01; 6(38):41146-61.
    View in: PubMed
    Score: 0.530
  7. MUC16-mediated activation of mTOR and c-Myc reprograms pancreatic cancer metabolism. Oncotarget. 2015 Aug 07; 6(22):19118-31.
    View in: PubMed
    Score: 0.518
  8. Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia. Cancer Metab. 2014; 2:18.
    View in: PubMed
    Score: 0.486
  9. DHODH inhibition enhances the efficacy of immune checkpoint blockade by increasing cancer cell antigen presentation. Elife. 2024 Jul 08; 12.
    View in: PubMed
    Score: 0.240
  10. Author Correction: Cancer-associated fibroblast-derived acetate promotes pancreatic cancer development by altering polyamine metabolism via the ACSS2-SP1-SAT1 axis. Nat Cell Biol. 2024 May; 26(5):840.
    View in: PubMed
    Score: 0.237
  11. The MUC1-HIF-1a signaling axis regulates pancreatic cancer pathogenesis through polyamine metabolism remodeling. Proc Natl Acad Sci U S A. 2024 Apr 02; 121(14):e2315509121.
    View in: PubMed
    Score: 0.236
  12. Cancer-associated fibroblast-derived acetate promotes pancreatic cancer development by altering polyamine metabolism via the ACSS2-SP1-SAT1 axis. Nat Cell Biol. 2024 Mar 01.
    View in: PubMed
    Score: 0.235
  13. DHODH inhibition enhances the efficacy of immune checkpoint blockade by increasing cancer cell antigen presentation. bioRxiv. 2023 Apr 05.
    View in: PubMed
    Score: 0.220
  14. ENT1 blockade by CNX-774 overcomes resistance to DHODH inhibition in pancreatic cancer. Cancer Lett. 2023 01 01; 552:215981.
    View in: PubMed
    Score: 0.214
  15. CD73 induces GM-CSF/MDSC-mediated suppression of T cells to accelerate pancreatic cancer pathogenesis. Oncogene. 2022 02; 41(7):971-982.
    View in: PubMed
    Score: 0.202
  16. Metabolic Rewiring by Loss of Sirt5 Promotes Kras-Induced Pancreatic Cancer Progression. Gastroenterology. 2021 11; 161(5):1584-1600.
    View in: PubMed
    Score: 0.195
  17. The Synergistic Effect of an ATP-Competitive Inhibitor of mTOR and Metformin on Pancreatic Tumor Growth. Curr Dev Nutr. 2020 Sep; 4(9):nzaa131.
    View in: PubMed
    Score: 0.183
  18. JNK signaling contributes to skeletal muscle wasting and protein turnover in pancreatic cancer cachexia. Cancer Lett. 2020 10 28; 491:70-77.
    View in: PubMed
    Score: 0.183
  19. SIRT1-NOX4 signaling axis regulates cancer cachexia. J Exp Med. 2020 07 06; 217(7).
    View in: PubMed
    Score: 0.182
  20. Macrophages potentiate STAT3 signaling in skeletal muscles and regulate pancreatic cancer cachexia. Cancer Lett. 2020 08 01; 484:29-39.
    View in: PubMed
    Score: 0.180
  21. Metabolic Alterations in Pancreatic Cancer Progression. Cancers (Basel). 2019 Dec 18; 12(1).
    View in: PubMed
    Score: 0.175
  22. Evaluating the Metabolic Alterations in Pancreatic Cancer. Methods Mol Biol. 2019; 1882:221-228.
    View in: PubMed
    Score: 0.164
  23. Microscale Gene Expression Analysis of Tumor-Associated Macrophages. Sci Rep. 2018 02 05; 8(1):2408.
    View in: PubMed
    Score: 0.154
  24. De Novo Lipid Synthesis Facilitates Gemcitabine Resistance through Endoplasmic Reticulum Stress in Pancreatic Cancer. Cancer Res. 2017 10 15; 77(20):5503-5517.
    View in: PubMed
    Score: 0.149
  25. MUC1-Mediated Metabolic Alterations Regulate Response to Radiotherapy in Pancreatic Cancer. Clin Cancer Res. 2017 Oct 01; 23(19):5881-5891.
    View in: PubMed
    Score: 0.148
  26. GOT1-mediated anaplerotic glutamine metabolism regulates chronic acidosis stress in pancreatic cancer cells. Cancer Lett. 2017 08 01; 400:37-46.
    View in: PubMed
    Score: 0.146
  27. Vitamin B6 competition in the tumor microenvironment hampers antitumor functions of NK cells. Cancer Discov. 2023 Nov 07.
    View in: PubMed
    Score: 0.057
  28. Ecdysoneless Overexpression Drives Mammary Tumorigenesis through Upregulation of C-MYC and Glucose Metabolism. Mol Cancer Res. 2022 09 02; 20(9):1391-1404.
    View in: PubMed
    Score: 0.053
  29. Visceral adipose tissue remodeling in pancreatic ductal adenocarcinoma cachexia: the role of activin A signaling. Sci Rep. 2022 01 31; 12(1):1659.
    View in: PubMed
    Score: 0.051
  30. IgE-Based Therapeutic Combination Enhances Antitumor Response in Preclinical Models of Pancreatic Cancer. Mol Cancer Ther. 2021 12; 20(12):2457-2468.
    View in: PubMed
    Score: 0.050
  31. Selective Inhibition of Histone Deacetylases 1/2/6 in Combination with Gemcitabine: A Promising Combination for Pancreatic Cancer Therapy. Cancers (Basel). 2019 Sep 07; 11(9).
    View in: PubMed
    Score: 0.043
  32. Glucose Limitation Alters Glutamine Metabolism in MUC1-Overexpressing Pancreatic Cancer Cells. J Proteome Res. 2017 10 06; 16(10):3536-3546.
    View in: PubMed
    Score: 0.037
  33. EGFR-Targeted Polymeric Mixed Micelles Carrying Gemcitabine for Treating Pancreatic Cancer. Biomacromolecules. 2016 Jan 11; 17(1):301-13.
    View in: PubMed
    Score: 0.033
  34. Active YAP promotes pancreatic cancer cell motility, invasion and tumorigenesis in a mitotic phosphorylation-dependent manner through LPAR3. Oncotarget. 2015 Nov 03; 6(34):36019-31.
    View in: PubMed
    Score: 0.033
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.